DPIIT recognised startup Government of India
Startup India
Hyper Biokem Private Limited
Hyper Biokem Private Limited - chemicals in Pune, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹52.46 Lakh
▲ 52% YoY
Net loss · FY 2025
₹10.87 Lakh
Net margin -20.7%
EBITDA · FY 2025
-₹3.81 Lakh
EBITDA margin -7.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
6
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Hyper Biokem Private Limited
Data last updated:
Hyper Biokem Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 May 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2022PTC211064.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Satheeshkumar Kandasamy and Sukhumar Thavasilingam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #15A 4th Floor City Vista Tower A Suite #152 Fountain Road Kharadi, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.46 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net loss of ₹10.87 Lakh (net margin -20.7%) and EBITDA of -₹3.81 Lakh (EBITDA margin -7.3%).
Hyper Biokem Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0145263).
Company details
CIN U24100PN2022PTC211064
Registration Number 211064
Incorporation Date 06 May 2022
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0145263
Key People
Satheeshkumar Kandasamy Director Sukhumar Thavasilingam Director Subramanian Muruganand Director Recognitions & Rankings of Hyper Biokem
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TN-02-0145263
Contact details
Hyper Biokem Private Limited's registered office is in Pune, Maharashtra.
- Registered Address#15A 4th Floor City Vista Tower A Suite #152 Fountain Road Kharadi, Pune, Maharashtra, India – 411014
- IndustryChemicals, Manufacturing, Basic Chemical
Comprehensive company report
Hyper Biokem Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hyper Biokem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hyper Biokem Private Limited, buy the company report.
Financials of Hyper Biokem Private Limited
FY 2025 filings availableHyper Biokem Private Limited reported revenue of ₹52.46 Lakh (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹52.46 Lakh ▲ 52%
Net loss · FY 2025
₹10.87 Lakh margin -20.7%
EBITDA · FY 2025
-₹3.81 Lakh margin -7.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
EBITDA CAGR growth
1 year
▲ 8%
Revenue rose 52% in the latest year. EBITDA rose 8% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.81 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹10.87 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -7.3% | ||
| Net Profit Margin | -20.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Hyper Biokem Private Limited, buy the company report.
Board of directors of Hyper Biokem Private Limited
Hyper Biokem has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satheeshkumar Kandasamy | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Sukhumar Thavasilingam Also directs: Sri Vari Network Private Limited | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Subramanian Muruganand | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Subramanian Murugaprakash | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Selvaraj Lakshmannan | Director | 06 May 2022 | 4 Years 5 Months | Current |
| Jeevanandam Ganesan | Director | 06 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Hyper Biokem Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chem-Needs (India) Private Limited | ₹52.67 Lakh (FY 2025) | 666.0% | Chennai, Tamil Nadu, India | |||
| Azico Pharmaceuticals Private Limited | ₹52.63 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Dhrubmeditech Pharmaceuticals Private Limited | ₹52.63 Lakh (FY 2025) | 10.0% | Gadarwara, Madhya Pradesh, India | |||
| Alpinia Biopharma Reema Private Limited | ₹52.59 Lakh (FY 2025) | 62.0% | Delhi, India | |||
| Isomer Healthcare Private Limited | ₹52.55 Lakh (FY 2018) | -1.0% | Sahibabad, Uttar Pradesh, India | |||
| Hyper Biokem Private Limitedthis company | ₹52.46 Lakh (FY 2025) | -₹10.87 Lakh | -20.7% | 52.0% | Pune, Maharashtra, India | |
| Stevels Pharma Limited | ₹52.36 Lakh (FY 2021) | -47.0% | Chandigarh, India | |||
| Om Medipharmaceuticals Private Limited | ₹52.35 Lakh (FY 2024) | -16.0% | Jaipur, Rajasthan, India | |||
| Earth Soil Mine Chem Private Limited | ₹52.34 Lakh (FY 2020) | -18.0% | Aburoad, Rajasthan, India | |||
| Ventex Nonwoven Private Limited | ₹52.32 Lakh (FY 2022) | -28.0% | Madurai, Tamil Nadu, India | |||
| Royal Pharmaceuticals Industries Private Limited | ₹52.28 Lakh (FY 2025) | 284.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hyper Biokem Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hyper Biokem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hyper Biokem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hyper Biokem Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hyper Biokem Private Limited has 6 board changes on record since 2022: 6 appointments. The latest: Jeevanandam Ganesan was appointed as Director on 06 May 2022.
AGM
Hyper Biokem Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hyper Biokem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Jeevanandam Ganesan was appointed as Director.
Appointed
Satheeshkumar Kandasamy was appointed as Director.
Appointed
Selvaraj Lakshmannan was appointed as Director.
Appointed
Subramanian Muruganand was appointed as Director.
Appointed
Subramanian Murugaprakash was appointed as Director.
Appointed
Sukhumar Thavasilingam was appointed as Director.
Incorporation
06 May 2022
Hyper Biokem Private Limited was registered on 06 May 2022 with Roc Pune & aged 4 years 5 months as per MCA records.
Frequently asked questions
Hyper Biokem is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 May 2022 (4+ years old) and is registered under CIN U24100PN2022PTC211064.
Hyper Biokem has 6 current directors:
- Satheeshkumar Kandasamy - Director
- Sukhumar Thavasilingam - Director
- Subramanian Muruganand - Director
- Subramanian Murugaprakash - Director
- Selvaraj Lakshmannan - Director
- Jeevanandam Ganesan - Director
The latest financial statements of Hyper Biokem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Hyper Biokem is U24100PN2022PTC211064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyper Biokem was incorporated on 06 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Hyper Biokem by revenue are Chem-Needs (India) Private Limited, Azico Pharmaceuticals Private Limited, Dhrubmeditech Pharmaceuticals Private Limited, Alpinia Biopharma Reema Private Limited, Isomer Healthcare Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jeevanandam Ganesan was appointed as Director on 06 May 2022. Satheeshkumar Kandasamy was appointed as Director on 06 May 2022. Selvaraj Lakshmannan was appointed as Director on 06 May 2022. Hyper Biokem has 6 board changes on record in total.
Yes, Hyper Biokem is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Hyper Biokem is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0145263).
The registered office of Hyper Biokem is at #15A 4th Floor City Vista Tower A Suite #152 Fountain Road Kharadi, Pune, Maharashtra, India – 411014.
Hyper Biokem operates in the chemicals industry, in the manufacturing segment.